24/7 Market News Snapshot 26 December, 2024 – Hoth Therapeutics, Inc. Common Stock (NASDAQ:HOTH)

December 26, 2024

DENVER, Colo., 26 December, 2024 (247marketnews.com) – (NASDAQ:HOTH) are discussed in this article.
Hoth Therapeutics, Inc. is currently experiencing fluctuations in its stock performance, opening today at $0.794, followed by a decline to approximately $0.758, representing a decrease of around 3.68%. The previous session concluded at $0.787, showcasing a sustained bearish trend. Current trading volume sits at 7.11 million shares, indicating an uptick in activity that may signal potential volatility. Investors are advised to monitor key technical indicators, such as relative strength index (RSI) and moving averages, to assess market conditions and identify strategic entry or exit points.

In a significant development, Hoth Therapeutics has successfully executed an exclusive patent license agreement with the U.S. Department of Veterans Affairs (VA), in collaboration with Emory University. This partnership grants Hoth exclusive rights to a groundbreaking patent portfolio centered on “Glial Cell Line-Derived Neurotrophic Factor, Obesity, and Obesity-Related Diseases and Conditions.” The innovative focus of this technology aims to address critical challenges associated with obesity and its related health issues.

CEO Robb Knie expressed enthusiasm for the collaboration, stating, “We are honored to work alongside the VA and Emory University in bringing this cutting-edge technology to market.” This agreement not only strengthens Hoth’s commitment to delivering transformative healthcare solutions but also includes a comprehensive development plan to transition the research into commercial applications effectively.

Moreover, Hoth Therapeutics is actively enhancing its intellectual property portfolio, having signed a letter of intent (LOI) for provisional patent protection for its lead therapeutic candidate, HT-001. Such strategic moves are poised to expand its pipeline within the cancer therapeutics domain, further underscoring the company’s dedication to advancing innovations that improve patient outcomes in the healthcare sector.

Related news for (HOTH)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.